[{"Assets_0_Q2_USD":3212321000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":217135000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":217549000.0,"EarningsPerShareBasic_1_Q2_USD":1.33,"EarningsPerShareBasic_2_Q2_USD":-1.98,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":217135000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":220434000.0,"EarningsPerShareDiluted_2_Q2_USD":-1.98,"StockholdersEquity_0_Q2_USD":2344604000.0,"RevenuesConverted_1_Q2_USD":688043000.0,"NetIncomeLossConverted_2_Q2_USD":-430344000.0,"NetIncomeLossConverted_1_Q2_USD":290298000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":-414035000.0,"CommonStockSharesOutstanding_0_Q2_shares":218069218.0,"CommonStockSharesConverted_0_Q2_shares":218069218.0,"RevenuesConverted_2_Q2_USD":1256550000.0,"EarningsPerShareDiluted_1_Q2_USD":1.32,"Ticker":"INCY","CIK":"879169","name":"INCYTE CORP","OfficialName":"Incyte Corp. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17588712770.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"SP500","filed":"20200804"}]